Publication: The selective cytotoxicity of silver thiosulfate, a silver complex, on MCF-7 breast cancer cells through ROS-induced cell death
Issued Date
2021-06-01
Resource Type
ISSN
17341140
Other identifier(s)
2-s2.0-85104832916
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pharmacological Reports. Vol.73, No.3 (2021), 847-857
Suggested Citation
Akira Ota, Masataka Tajima, Kazunori Mori, Erika Sugiyama, Vilasinee Hirunpanich Sato, Hitoshi Sato The selective cytotoxicity of silver thiosulfate, a silver complex, on MCF-7 breast cancer cells through ROS-induced cell death. Pharmacological Reports. Vol.73, No.3 (2021), 847-857. doi:10.1007/s43440-021-00260-0 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78960
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The selective cytotoxicity of silver thiosulfate, a silver complex, on MCF-7 breast cancer cells through ROS-induced cell death
Other Contributor(s)
Abstract
Background: Silver is a transition metal that is known to be less toxic than platinum. However, only few studies have reported the anticancer effects of some silver complexes and their possibility as an alternative to platinum complex. This study investigated the anticancer effects of the silver thiosulfate complex (STS), [Ag(S2O3)2]3−, consisting of silver and sodium thiosulfate. Methods: In vitro cytotoxic activity of STS was investigated comparatively in human cancer cell lines (K562 and MCF-7) and normal human cells (mesenchymal stem cells and mammary epithelial cells). For its anticancer effects, cell cycle, mode of cell death, morphological changes, and accumulation of intracellular ROS and GSH were evaluated in MCF-7 to provide mechanistic insights. Results: STS showed a concentration-dependent cytotoxicity in MCF-7 cell, which was abolished by pretreatment with N-acetylcysteine, suggesting ROS accumulation by STS. Moreover, STS caused cell cycle arrest at the G1 phase, decrease in the GSH levels, and morphological changes in MCF-7. Direct measurement of ROS demonstrated the elevation of intracellular ROS accumulation in cancer cells treated with STS; however, neither cytotoxicity nor ROS accumulation was observed in normal human cells. Conclusion: The results obtained here are the first evidence to show that STS exhibited an anticancer activity through ROS-induced mechanisms, and that its cytotoxicity is highly selective to cancer cells. The results of the present study warrant further investigation on the detailed mechanism of STS actions, as well as its in vivo effectiveness and safety for clinical application.